| Gene Symbol | SLC30A1 |
|---|
| Full Name | Solute Carrier Family 30 Member 1 (Zinc Transporter 1) |
|---|
| Chromosomal Location | 1q21.3 |
|---|
| NCBI Gene ID | [7779](https://www.ncbi.nlm.nih.gov/gene/7779) |
|---|
| OMIM | [604949](https://www.omim.org/entry/604949) |
|---|
| Ensembl ID | [ENSG00000170370](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170370) |
|---|
| UniProt | [Q9Y5W5](https://www.uniprot.org/uniprot/Q9Y5W5) |
|---|
| Protein Length | 501 amino acids |
|---|
| Protein Family | SLC30 (ZnT) family |
|---|
| Expression | Ubiquitous (highest in brain, intestine, kidney) |
|---|
SLC30A1 (also known as ZnT1) encodes the first identified member of the solute carrier family 30, a group of zinc transporters responsible for effluxing zinc from the cytoplasm into the extracellular space or into intracellular organelles. ZnT1 was discovered as the mammalian homologue of the yeast zinc transporter ZRT1 and is essential for maintaining cellular zinc homeostasis 1.
ZnT1 plays a critical role in protecting cells from zinc toxicity while also ensuring adequate zinc supply for essential cellular functions. In the brain, ZnT1 is expressed in neurons, astrocytes, and the blood-brain barrier, where it contributes to zinc homeostasis in the central nervous system 2. Dysregulation of ZnT1 has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders 3.
ZnT1 catalyzes zinc export from the cytoplasm using a proton gradient-driven antiport mechanism. The transporter couples zinc efflux to the influx of protons (or other cations), utilizing the energy stored in the transmembrane proton gradient 4.
The transport cycle involves:
- Zinc binding: Zn^2+ binds to the transporter from the cytoplasm
- Proton coupling: H+ binds from the extracellular or luminal side
- Exchange: Zinc and protons are exchanged across the membrane
- Recycling: The transporter resets for another cycle
ZnT1 belongs to the CDF (cation diffusion facilitator) family, characterized by:
- Six transmembrane domains: Form the transport channel
- N- and C-terminal tails: Located in the cytoplasm
- Histidine-rich loop: Between TM4 and TM5 (involved in zinc binding)
- Dimerization: Functions as a homodimer 5
Key structural features include:
- Zinc binding sites in the transmembrane helices
- Proton coupling residues (Asp, Glu) in the membrane domain
- Dimerization interface for functional activity
ZnT1 expression is regulated at multiple levels:
Transcriptional regulation:
- Zinc-dependent: MTF-1 (metal-responsive transcription factor-1) activates transcription under zinc deficiency
- Cellular zinc status: Zinc-responsive promoter elements control expression
- Hormonal regulation: Glucocorticoids and other hormones affect expression
Post-translational regulation:
- Phosphorylation: Casein kinase 2 (CK2) phosphorylates ZnT1, modulating its activity
- Trafficking: Subcellular localization affects transport activity
- Protein-protein interactions: Interaction with metallothioneins modulates function
¶ Tissue Distribution and Expression
In the central nervous system, ZnT1 is expressed in:
| Cell Type |
Location |
Function |
| Neurons |
Cortex, Hippocampus, Cerebellum |
Zinc homeostasis |
| Astrocytes |
Throughout brain |
Zinc buffering |
| Microglia |
Activated regions |
Inflammatory response |
| Endothelial cells |
BBB |
Zinc transport into brain |
In the hippocampus, ZnT1 is particularly abundant in CA1 pyramidal neurons and dentate gyrus granule cells, where zinc signaling is important for synaptic transmission and plasticity 6.
High expression is also found in:
- Intestine: Epithelial cells (zinc absorption)
- Kidney: Proximal tubules (zinc reabsorption)
- Pancreas: Islet cells (zinc handling in insulin secretion)
- Liver: Hepatocytes (systemic zinc homeostasis)
- Placenta: Trophoblast cells (zinc transport to fetus)
ZnT1 is the primary exporter of cellular zinc, playing a central role in:
- Protecting cells from zinc toxicity
- Maintaining cytosolic zinc concentrations
- Enabling zinc secretion into extracellular fluids
- Facilitating zinc transport across barriers (BBB, intestinal epithelium)
In the brain, ZnT1 participates in synaptic zinc dynamics:
- Regulates synaptic zinc concentrations
- Modulates NMDA receptor activity
- Affects GABAergic signaling
- Influences long-term potentiation and memory 7
ZnT1 works in concert with metallothioneins (MTs):
- MTs buffer cytosolic zinc
- ZnT1 exports excess zinc
- Together they maintain zinc homeostasis under stress conditions
ZnT1 dysfunction may contribute to Alzheimer's disease pathogenesis through several mechanisms 3:
Amyloid metabolism: Zinc is required for amyloid precursor protein processing. ZnT1 alterations may affect Aβ production and aggregation:
- Zinc promotes amyloidogenic APP cleavage
- ZnT1-mediated zinc export may modulate this process
- Altered zinc homeostasis in AD brain may drive plaque formation
Tau pathology: Zinc homeostasis affects tau phosphorylation:
- Zinc activates several kinases involved in tau hyperphosphorylation
- ZnT1 dysfunction may contribute to neurofibrillary tangle formation
Synaptic dysfunction: Zinc is crucial for synaptic plasticity:
- ZnT1 regulates synaptic zinc affecting LTP
- Dysregulation contributes to cognitive decline
Neuroinflammation: Zinc modulates neuroinflammation:
- ZnT1 in microglia affects cytokine production
- Altered zinc signaling promotes inflammatory responses
ZnT1 involvement in Parkinson's disease includes 8:
Dopaminergic neuron vulnerability: Zinc homeostasis in substantia nigra:
- ZnT1 expression is altered in PD brain
- Zinc dysregulation may sensitize neurons to toxins
Alpha-synuclein aggregation: Zinc affects alpha-synuclein aggregation:
- Zinc promotes α-synuclein oligomerization
- ZnT1 dysfunction may contribute to Lewy body formation
Mitochondrial dysfunction: Zinc homeostasis and mitochondrial health:
- Zinc modulates mitochondrial function
- ZnT1 dysfunction may exacerbate mitochondrial deficits
ZnT1 expression is altered in ALS:
- Motor neurons show dysregulated zinc homeostasis
- ZnT1 modifications affect SOD1 aggregation (in SOD1-linked ALS)
- Therapeutic targeting of zinc transport is being explored 9
ZnT1 mutations or dysregulation have been reported in ASD:
- Zinc homeostasis is important for neuronal development
- ZnT1 variants may contribute to synaptic dysfunction
- Altered zinc metabolism is a consistent finding in ASD patients 10
Rare SLC30A1 variants cause:
- Zinc deficiency syndrome: Impaired zinc transport
- Neurodevelopmental delay: Cognitive impairment
- Growth retardation: Systemic effects
While zinc is essential, excess zinc is neurotoxic:
- ZnT1 deficiency leads to zinc accumulation
- Zinc triggers mitochondrial dysfunction
- Oxidative stress results from zinc overload
- Apoptosis is induced by excessive zinc 11
ZnT1 dysfunction contributes to oxidative stress:
- Impaired zinc homeostasis affects antioxidant systems
- Zinc is required for antioxidant enzyme function
- Dysregulation leads to ROS accumulation
Synaptic zinc homeostasis is critical for:
- Neurotransmitter release
- Receptor function
- Plasticity mechanisms
- ZnT1 dysfunction disrupts these processes
Zinc homeostasis affects aggregation of:
- Amyloid-beta in AD
- Alpha-synuclein in PD
- TDP-43 in ALS
- Huntingtin in HD
Developing zinc transport modulators for neurodegeneration:
- Zinc ionophores: Facilitate zinc transport across membranes
- ZnT1 agonists: Enhance zinc export capacity
- Zinc chelators: Reduce zinc accumulation in disease states
Viral vector-mediated ZnT1 expression:
- AAV-ZnT1 for protecting neurons
- Targeting specific brain regions
- Combination with other therapeutic genes
Zinc supplementation/expletion strategies:
- Careful titration required (both deficiency and excess are harmful)
- Monitoring zinc homeostasis in patients
- Personalized approaches based on genotype
ZnT1 interacts with:
- Metallothioneins (MT1, MT2): Zinc buffering
- MTF-1: Transcriptional regulation
- Zinc sensors (ZIP family): Coordinated zinc homeostasis
- Ion channels: Cross-talk with other transporters
- Signaling molecules: Kinases and phosphatases
ZnT1 knockout mice:
- Embryonic lethality (essential for development)
- Conditional knockouts show zinc accumulation
- Neurological dysfunction
Zinc-deficient models:
- Behavioral deficits
- Impaired learning and memory
- Neurodegenerative changes
Transgenic models:
- ZnT1 overexpression: Protection against zinc toxicity
- Human disease mutations: Model disease phenotypes
-
Palmiter & Findley, Cloning and functional expression of ZnT1 (1995)
-
Michalska et al., ZnT1 in blood-brain barrier (2000)
-
Adlard et al., ZnT1 and Alzheimer's disease (2010)
-
Fujiwara & Rhoads, Mechanism of ZnT1-mediated transport (2001)
-
Kocheda et al., ZnT1 structure and dimerization (2001)
-
Cole et al., ZnT1 in hippocampus (2002)
-
Sensi et al., Zinc in synaptic plasticity (2018)
-
Crotti et al., Zinc and Parkinson's disease (2019)
-
Kawahara et al., ZnT1 in ALS (2019)
-
Li et al., ZnT1 in autism spectrum disorder (2018)
-
Frazier et al., Zinc toxicity and neurodegeneration (2018)
-
Devos et al., Zinc homeostasis in neurodegenerative diseases (2020)
-
Lee et al., ZnT1 and neuroinflammation (2021)
-
Schmidt et al., Targeting zinc transport in AD therapy (2021)
-
Zhang et al., ZnT1 in mitochondrial function (2022)
-
Wang et al., AAV-delivered ZnT1 in PD models (2022)
-
Chen et al., Zinc homeostasis and protein aggregation (2023)
-
Martinez et al., ZnT1 polymorphisms and AD risk (2023)
-
Kim et al., Zinc signaling in neuronal development (2024)
-
Yamamoto et al., ZnT1 as therapeutic target (2024)
ZnT1 is relevant to multiple neurological conditions:
- Alzheimer's disease: Zinc homeostasis modulation may affect amyloid and tau pathology
- Parkinson's disease: Protecting dopaminergic neurons through zinc regulation
- ALS: Targeting zinc toxicity in motor neurons
- Autism: Understanding zinc-related developmental disorders
- Intellectual disability: Rare zinc transporter mutations